GALNT5 fuels colorectal cancer growth and drug resistance through PI3K/Akt/ABCC1 pathway
Every year, hundreds of thousands of patients with colorectal cancer are placed on a drug combination that oncology has trusted...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
Every year, hundreds of thousands of patients with colorectal cancer are placed on a drug combination that oncology has trusted...
Everyday chemicals that quietly interfere with hormones—from the bisphenols lining food cans to the "forever chemicals" lingering in drinking water—may...
Glioblastoma, the most aggressive primary brain cancer in adults, has long defeated the standard chemotherapeutic temozolomide through a frustrating combination...
Lung cancer is the world's deadliest cancer, and yet the way medicine measures it has barely changed in decades. A...
The most consequential decision in the treatment of a deep soft tissue sarcoma is often made before a single incision...
The vascular biology community has just been handed both a discovery and a warning in a single package. In a...
In medicine's long catalogue of rare events, few sights arrest a hematologist like the same cancer surfacing twice within a...
In one of oncology's most closely watched experiments, an antibody-drug conjugate paired with an immune checkpoint inhibitor has produced unusually...
Pancreatic cancer has earned its grim reputation the hard way. Fewer than one in eight patients survives five years beyond...
For more than three decades, the mammogram has been one of medicine's most stubbornly standardized rituals: a woman reaches the...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine